Skip to main content

Table 1 Demographic characteristics of study participants

From: Genomic characterization of remission in juvenile idiopathic arthritis

Training group
Response to methotrexate Response to methotrexate + etanercept Healthy control
Patients Age Time to CRM Patients Age Time to CRM Control Age
   (month)   (month)    
1 9 7 1 13 20 1 16
2 16 8 2 3 24 2 18
3* 11 10 3 3 48 3 9
4 7 14 4 6 8 4 11
5 11 12 5 4 18 5 10
6* 6 15 6 5 42 6 11
7 7 32 7 14 15 7 10
8* 11 13 8 9 25 8 10
9 7 36 9 10 30 9 11
10 4 46 10 15 25 10 13
11 11 8 11 11 20 11 13
12 7 15 12 12 24 12 10
13 11 48 13 12 24 13 12
14* 6 9 14 7 11 14 12
Testing group
Response to methotrexate Response to methotrexate + etanercept Healthy control
Patients Age Time to CRM Patients Age Time to CRM Control Age
  (month)     (month)   
1 12 27 1 9 24 1 12
2 5 12 2 17 10 2 15
3 12 11 3 6 17 3 8
4 14 11 4 7 26 4 9
5 16 11 5 12 26 5 8
6 5 13 6 5 18 6 11
7 4 10 7 6 24 7 15
8 7 17 8 15 16 8 11
  1. *RNA from granulocytes was insufficient for microarray analysis. CRM, clinical remission on medication.